Corrigendum to "Co-delivery of Poria cocos extract and doxorubicin as an 'all-in-one' nanocarrier to combat breast cancer multidrug resistance during chemotherapy" [Nanomedicine: Nanotechnology, Biology, and Medicine 23 (2020) 102095].

Nanomedicine

Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, China. Electronic address:

Published: July 2021

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.nano.2020.102336	DOI Listing

Publication Analysis

corrigendum "co-delivery

"co-delivery poria

poria cocos

cocos extract

extract doxorubicin

doxorubicin 'all-in-one'

'all-in-one' nanocarrier

nanocarrier combat

combat breast

breast cancer

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!